OVARIAN, FALLOPIAN TUBE AND PRIMARY PERITONEAL CARCINOMA

Clinical trials for OVARIAN, FALLOPIAN TUBE AND PRIMARY PERITONEAL CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new OVARIAN, FALLOPIAN TUBE AND PRIMARY PERITONEAL CARCINOMA trials appear

Sign up with your email to follow new studies for OVARIAN, FALLOPIAN TUBE AND PRIMARY PERITONEAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Major trial aims to extend life for women with advanced ovarian cancer

Disease control Ongoing

This large, late-stage study is testing whether adding two newer drugs (dostarlimab and niraparib) to standard chemotherapy works better than standard care alone for women newly diagnosed with advanced ovarian cancer. The main goal is to see if the new combination can keep the ca…

Matched conditions: OVARIAN, FALLOPIAN TUBE AND PRIMARY PERITONEAL CARCINOMA

Phase: PHASE3 • Sponsor: Tesaro, Inc. • Aim: Disease control

Last updated Apr 01, 2026 14:42 UTC

OVARIAN, FALLOPIAN TUBE AND PRIMARY PERITONEAL CARCINOMA

Get alerted when new OVARIAN, FALLOPIAN TUBE AND PRIMARY PERITONEAL CARCINOMA trials appear

Major trial aims to extend life for women with advanced ovarian cancer